Flavonoids: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
::::* https://www.researchgate.net/publication/338436124_Flavonoids_and_type_2_diabetes_Evidence_of_efficacy_in_clinical_and_animal_studies_and_delivery_strategies_to_enhance_their_therapeutic_efficacy | ::::* https://www.researchgate.net/publication/338436124_Flavonoids_and_type_2_diabetes_Evidence_of_efficacy_in_clinical_and_animal_studies_and_delivery_strategies_to_enhance_their_therapeutic_efficacy | ||
[[Category:MitObesity]] | [[Category:BME and MitObesity]] | ||
Revision as of 18:44, 19 January 2020
- high-resolution terminology - matching measurements at high-resolution
Flavonoids
Description
Flavonoids are a group of bioactive polyphenols with potential antioxidant and anti-inflammatory effects, abundant in fruits and vegetables, and in some medicinal herbs. Flavonoids are synthesized in plants from phenylalanine. Dietary intake of flavonoids as nutraceuticals is discussed for targeting T2D and other degenerative diseases.
Flavonoids and MitObesity
- Messerli FH (2012) Chocolate consumption, cognitive function, and Nobel laureates. New England J Med 367:1562-4. - »Bioblast link«
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946223/
- https://www.researchgate.net/publication/338436124_Flavonoids_and_type_2_diabetes_Evidence_of_efficacy_in_clinical_and_animal_studies_and_delivery_strategies_to_enhance_their_therapeutic_efficacy
